These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 12966640

  • 21. Can sudden cardiac death be prevented?
    Maron BJ.
    Cardiovasc Pathol; 2010; 19(6):329-35. PubMed ID: 20378375
    [Abstract] [Full Text] [Related]

  • 22. Ventricular fibrillation during sleep in an adolescent with hypertrophic cardiomyopathy: the difficulty of risk stratification and the power of the cardioverter-defibrillator.
    Boriani G, Biffi M, Rapezzi C, Coccolo F, Branzi A, Spirito P.
    Int J Cardiol; 2004 Oct; 97(1):143-4. PubMed ID: 15336824
    [No Abstract] [Full Text] [Related]

  • 23. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.
    McLeod CJ, Ackerman MJ, Nishimura RA, Tajik AJ, Gersh BJ, Ommen SR.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):229-33. PubMed ID: 19589435
    [Abstract] [Full Text] [Related]

  • 24. Failure of amiodarone to prevent ventricular fibrillation (sudden death) in hypertrophic cardiomyopathy.
    Mercereau D, Kubac G, Klinke WP.
    Can J Cardiol; 1989 Mar 14; 5(2):77-80. PubMed ID: 2706577
    [Abstract] [Full Text] [Related]

  • 25. Hypertrophic cardiomyopathy: case report.
    Mukhtar AU, Ihunwo AO.
    East Afr Med J; 1999 Sep 14; 76(9):535-6. PubMed ID: 10685328
    [Abstract] [Full Text] [Related]

  • 26. [Hemodynamic and electrophysiologic changes in hypertrophic cardiomyopathy].
    López Gil M, Tascón Pérez J, Albarrán A, Arribas F, Alonso M, García-Cosío F.
    Rev Esp Cardiol; 1996 Jan 14; 49(1):56-68. PubMed ID: 8685513
    [Abstract] [Full Text] [Related]

  • 27. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ, Spirito P.
    J Cardiovasc Electrophysiol; 2008 Oct 14; 19(10):1118-26. PubMed ID: 18384577
    [Abstract] [Full Text] [Related]

  • 28. [Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy].
    Spirito P, Piccininno M.
    Ital Heart J Suppl; 2000 Jun 14; 1(6):840-1. PubMed ID: 11204022
    [No Abstract] [Full Text] [Related]

  • 29. [Therapy of arrhythmias in hypertrophic cardiomyopathy].
    Rapezzi C, Spirito P.
    G Ital Cardiol; 1995 Nov 14; 25(11):1443-6. PubMed ID: 8682242
    [No Abstract] [Full Text] [Related]

  • 30. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
    Basso C, Thiene G, Mackey-Bojack S, Frigo AC, Corrado D, Maron BJ.
    Eur Heart J; 2009 Jul 14; 30(13):1627-34. PubMed ID: 19406869
    [Abstract] [Full Text] [Related]

  • 31. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy].
    Wang Y, Cui YH, Wang DW.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):401-4. PubMed ID: 15061995
    [Abstract] [Full Text] [Related]

  • 32. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.
    Heart; 2009 May 02; 95(9):709-14. PubMed ID: 19282314
    [Abstract] [Full Text] [Related]

  • 33. [Hypertrophic cardiomyopathy: from diagnosis to prevention].
    Hassink RJ, Grosfeld MJ, Marcelis C, Delhaas T, Doevendans PA.
    Ned Tijdschr Geneeskd; 2003 Jun 14; 147(24):1181-4. PubMed ID: 12845840
    [Abstract] [Full Text] [Related]

  • 34. [Hypertrophic cardiomyopathy with two episodes of recuperated sudden death. Report of the first implantable defibrillator cardioverter inserted in Chile].
    Zalaquett R, Fajuri A, Irarrázaval MJ, Neghme R, Vergara I, Sacco C, Dubernet J, Corbalán R.
    Rev Med Chil; 1994 Oct 14; 122(10):1171-7. PubMed ID: 7659885
    [Abstract] [Full Text] [Related]

  • 35. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 36. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M, Ben Ameur I, Kechida Z, Charfeddine H, Hached L, Grati Z, Kammoun S.
    Tunis Med; 2003 Mar 01; 81 Suppl 8():675-9. PubMed ID: 14608758
    [Abstract] [Full Text] [Related]

  • 37. [Arrhythmic syndrome and sudden death in hypertrophic cardiomyopathy].
    Storozhakov GI, Selivanov AI, Kisliak OA.
    Ter Arkh; 1988 Mar 01; 60(8):137-41. PubMed ID: 2906486
    [No Abstract] [Full Text] [Related]

  • 38. [Genetic aspects of the etiology of arrhythmia].
    Thierfelder L.
    Z Kardiol; 2000 Mar 01; 89 Suppl 3():1-5. PubMed ID: 10810779
    [Abstract] [Full Text] [Related]

  • 39. Prognostic value of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Fatkin D, Graham RM.
    N Engl J Med; 2001 Jan 04; 344(1):63-5. PubMed ID: 11187116
    [No Abstract] [Full Text] [Related]

  • 40. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy.
    Christiaans I, Birnie E, Bonsel GJ, Wilde AA, van Langen IM.
    Eur J Hum Genet; 2008 Oct 04; 16(10):1201-7. PubMed ID: 18478037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.